
Nano-X Imaging (NNOX) Stock Forecast & Price Target
Nano-X Imaging (NNOX) Analyst Ratings
Bulls say
Nano X Imaging has reported quarterly revenue of $3.4 million, marking an increase from $3.0 million in the prior quarter, attributed to stronger teleradiology utilization and improved margins. The company has reaffirmed its goal to surpass 100 deployed units globally by year-end and has issued a robust revenue guidance of $35 million for 2026, indicating confidence in unit placement and monetization across various revenue channels. Additionally, a strategic partnership with 3DR Labs to distribute its AI imaging solutions across over 1,800 hospitals enhances its commercial footprint and supports future growth prospects for its imaging ecosystem.
Bears say
Nano X Imaging Ltd's cash reserves have decreased significantly from $83.2 million to $55.5 million, primarily due to an operating cash burn of $30.4 million, indicating financial strain. The company has also been adjusting its revenue growth expectations downward over the past year, signaling potential challenges in market demand or operational effectiveness. Furthermore, the sustained GAAP gross loss of $2.9 million and consistent net loss of $13.7 million highlight ongoing financial difficulties tied to investments in system deployments and AI infrastructure.
This aggregate rating is based on analysts' research of Nano-X Imaging and is not a guaranteed prediction by Public.com or investment advice.
Nano-X Imaging (NNOX) Analyst Forecast & Price Prediction
Start investing in Nano-X Imaging (NNOX)
Order type
Buy in
Order amount
Est. shares
0 shares